A psychedelic is a substance that profoundly alters perception, thought, and emotion by acting on serotonin receptors in the brain. The word itself was coined in 1957 by the psychiatrist Humphry Osmond, who combined two Greek words: psyche (mind or soul) and deloun (to show or reveal). In the most literal sense, a psychedelic is something that “reveals the mind.” That poetic definition still holds up surprisingly well against what modern neuroscience has uncovered about how these substances work.
How Psychedelics Work in the Brain
Classic psychedelics produce their effects primarily by binding to a specific serotonin receptor called 5-HT2A. Serotonin is one of the brain’s key chemical messengers, involved in mood, perception, and cognition. When a psychedelic molecule locks onto this receptor, it triggers a cascade of signaling inside the cell, including the release of calcium stores and activation of pathways that don’t normally fire in the same patterns. The result is a dramatic shift in how the brain processes sensory information and constructs your sense of reality.
One of the most studied effects is the disruption of something called the default mode network, a set of brain regions that are active when you’re daydreaming, thinking about yourself, or mentally time-traveling through memories. This network is closely tied to your sense of identity and the running narrative in your head. Psychedelics consistently reduce connectivity within this network while increasing communication between brain regions that don’t usually talk to each other. That rewiring is thought to explain many of the hallmark experiences: a dissolving sense of self, feelings of unity with surroundings, and the impression that time has stopped or become meaningless.
The Three Chemical Families
Classic psychedelics fall into three structural categories, each resembling a naturally occurring chemical in the body.
- Tryptamines closely resemble serotonin itself. This group includes psilocin (the active compound in magic mushrooms), DMT (the primary psychoactive ingredient in ayahuasca), and 5-MeO-DMT (found in certain toad secretions).
- Ergolines are rigid, complex molecules derived from ergot alkaloids, a type of fungus that grows on grain. LSD is the most well-known ergoline and one of the most potent psychedelics by weight.
- Phenethylamines share a structural resemblance to dopamine. Mescaline, the psychoactive compound in peyote and San Pedro cacti, is the best-known example. This family spans a wide range of potencies.
Despite their different shapes, all three families converge on the same target: the 5-HT2A serotonin receptor. The differences in structure do influence how long effects last, how intense they feel, and what secondary receptors get activated, which is why a psilocybin experience feels distinct from an LSD experience even though both are “classic” psychedelics.
What a Psychedelic Experience Feels Like
The subjective effects of psychedelics span a broad range, from shifts in visual perception (geometric patterns, intensified colors, surfaces appearing to breathe) to deep emotional states and altered thinking. Time distortion is extremely common. Users frequently report feeling as though time is standing still or that minutes have stretched into hours. Psilocybin experiences typically last four to six hours, while LSD can last 8 to 12.
Beyond sensory changes, psychedelics reliably produce experiences that people describe as deeply meaningful. Research using standardized rating scales has found that meaningfulness is one of the dimensions that uniquely distinguishes psychedelics from other mind-altering substances. People report feelings of euphoria, a sense of oneness with others or with nature, and encounters with ideas or emotions that feel profoundly significant. Not every experience is pleasant, though. Anxiety, confusion, and frightening imagery can also occur, particularly at higher doses or in unsupportive settings.
Psychedelics vs. Dissociatives and Entactogens
The word “psychedelic” gets used loosely in popular culture, so it helps to understand what does and doesn’t fit the definition. Classic psychedelics, like LSD and psilocybin, are defined by their direct activation of 5-HT2A receptors. Two other drug classes sometimes get lumped in with them but work through fundamentally different mechanisms.
Entactogens, most famously MDMA (ecstasy), don’t directly activate serotonin receptors the way psychedelics do. Instead, they flood the brain with serotonin by forcing its release from nerve cells. The result is less about altered perception and more about emotional openness, reduced fear, and a sense of closeness to others. The name “entactogen” means “touching within,” reflecting the way these substances help people access repressed memories and emotions. MDMA generally does not produce hallucinations.
Dissociative anesthetics like ketamine can produce altered states that overlap with psychedelic experiences, including perceptual distortion and ego dissolution, but they work primarily by blocking a different receptor entirely. Whether ketamine qualifies as a psychedelic remains a point of debate among researchers.
Ancient Roots, Modern Science
Humans have been using psychedelic plants for thousands of years. Archaeological evidence from present-day Bolivia includes shamanic snuffs containing DMT and other compounds dating back roughly 1,000 years. Ceramic vessels linked to ayahuasca rituals in the Amazon have been dated to around 2400 BC. Indigenous groups like the Shipibo have long regarded ayahuasca as a plant teacher used by shamans for diagnosis and healing, and peyote holds deep ceremonial significance for Native American traditions.
Western science caught up in the mid-20th century, and after decades of legal restrictions, clinical research has accelerated significantly. The FDA granted breakthrough therapy designations to psilocybin for treatment-resistant depression in 2018 and for major depressive disorder in 2019. MDMA received the same designation for post-traumatic stress disorder in 2017. Clinical trials are now exploring psilocybin’s potential for cancer-related anxiety, eating disorders, substance use disorders, and chronic pain.
Safety Profile
Classic psychedelics are generally considered physiologically safe, with low toxicity and low addictive potential. Unlike opioids or stimulants, they do not produce physical dependence, and the body builds rapid tolerance that discourages compulsive redosing. The most commonly observed physical effects with psilocybin are temporary increases in heart rate and blood pressure, which are dose-dependent and typically resolve without medical intervention. LSD shows a similar cardiovascular safety profile in studies involving healthy volunteers.
That said, “physiologically safe” is not the same as “risk-free.” High doses in uncontrolled settings have been linked to dangerous reactions, including severe blood vessel constriction. The psychological risks are real too: intense anxiety, paranoia, and disorientation can occur, and people with a personal or family history of psychotic disorders face elevated risk. Context matters enormously. The same substance that produces a transcendent experience in a calm, supervised setting can trigger a terrifying one in a chaotic or unsafe environment.